Results 131 to 140 of about 289,373 (313)
Clinical and Applied Thrombosis/HemostasisThis study aimed to evaluate the safety and efficacy of pharmacomechanical catheter-directed thrombolysis (PCDT) and stenting for treating acute iliofemoral deep venous thrombosis (DVT) combined with iliac vein compression syndrome (IVCS), and to ...
Lin Zhang MM +5 more
doaj +1 more source
Recoil following Wiktor stent implantation for restenotic lesions of coronary arteries [PDF]
, 1994 The purpose of this study was to determine acute recoil of the vessel wall immediately after Wiktor stent implantation in native coronary arteries of 77 consecutive patients and to assess whether there was compression or “late recoil” of the stent itself
Bertrand, M.E. (Michel) +11 more
core +1 more source
Drug Coated Balloons Versus Drug‐Eluting Stents in Patients With De Novo Coronary Artery Disease
Catheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1843-1853, September 1, 2025.ABSTRACT Background In patients with de novo coronary artery disease (CAD), percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation is the gold standard therapy. New evidence is available with drug coated balloons (DCB) angioplasty. The objective of this meta‐analysis was to compare the efficacy and safety of DCB angioplasty
Daniel O'Callaghan +9 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1951-1957, September 1, 2025.ABSTRACT Background Initially, drug‐coated balloon (DCB) angioplasty was primarily employed for in‐stent restenosis (ISR) treatment. Over time, its indications have broadened to include de novo small‐vessel lesions and bifurcation lesions. However, there is a lack of effective strategies to reduce restenosis rates post‐DCB angioplasty.
Chenhang Wang, Li Chen, Xiaoyong Xu
wiley +1 more source
A new approach to planning in vitro and in vivo experiments for cardiovascular stents. (1) Fundamentals of design procedures [PDF]
, 2000 Copyright @ 2000 Pacini Editore SpAWhile the use of cardiovascular stents is internationally widespread re-stenosis remains a common problem. There are a number of different designs, and this project seeks for design improvements leading to a reduction ...
Atherton, MA, Collins, MW, Doorly, DJ
core
, 2018 We use a one-dimensional two layer model with a semi-permeable membrane to study the diffusion of a therapeutic drug delivered from a drug-eluting stent (DES).
Farago, Oded, Regev, Shaked
core +1 more source
Time course of restenosis during the first year after emergency coronary stenting. [PDF]
, 1993 Adnan Kastrati +4 more
openalex +1 more source
Catheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1993-2004, September 1, 2025.ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane +11 more
wiley +1 more source
Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention [PDF]
, 2001 BACKGROUND: Angiographic restenosis after percutaneous coronary interventional procedures is more common than recurrent angina. Clinical and angiographic factors associated with asymptomatic versus symptomatic restenosis after percutaneous coronary ...
Es, G.A. (Gerrit Anne) van +6 more
core +2 more sources